2iiv
From Proteopedia
Line 1: | Line 1: | ||
[[Image:2iiv.gif|left|200px]] | [[Image:2iiv.gif|left|200px]] | ||
- | + | <!-- | |
- | + | The line below this paragraph, containing "STRUCTURE_2iiv", creates the "Structure Box" on the page. | |
- | + | You may change the PDB parameter (which sets the PDB file loaded into the applet) | |
- | + | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |
- | + | or leave the SCENE parameter empty for the default display. | |
- | | | + | --> |
- | | | + | {{STRUCTURE_2iiv| PDB=2iiv | SCENE= }} |
- | + | ||
- | + | ||
- | }} | + | |
'''Human dipeptidyl peptidase 4 in complex with a diazepan-2-one inhibitor''' | '''Human dipeptidyl peptidase 4 in complex with a diazepan-2-one inhibitor''' | ||
Line 29: | Line 26: | ||
[[Category: Scapin, G.]] | [[Category: Scapin, G.]] | ||
[[Category: Weber, A E.]] | [[Category: Weber, A E.]] | ||
- | [[Category: | + | [[Category: Alpha/beta]] |
- | [[Category: | + | [[Category: Beta-propeller]] |
- | [[Category: | + | [[Category: Dimer]] |
- | [[Category: | + | [[Category: Hydrolase]] |
- | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 07:33:27 2008'' | |
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + |
Revision as of 04:33, 4 May 2008
Human dipeptidyl peptidase 4 in complex with a diazepan-2-one inhibitor
Overview
Replacement of the triazolopiperazine ring of sitagliptin (DPP-4 IC(50)=18nM) with 3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one gave dipeptidyl peptidase IV (DPP-4) inhibitor 1 which is potent (DPP-4 IC(50)=2.6nM), selective, and efficacious in an oral glucose tolerance test in mice. It was selected for extensive preclinical development as a potential back-up candidate to sitagliptin.
About this Structure
2IIV is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
(3R)-4-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(2,2,2-trifluoro ethyl)-1,4-diazepan-2-one, a selective dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes., Biftu T, Feng D, Qian X, Liang GB, Kieczykowski G, Eiermann G, He H, Leiting B, Lyons K, Petrov A, Sinha-Roy R, Zhang B, Scapin G, Patel S, Gao YD, Singh S, Wu J, Zhang X, Thornberry NA, Weber AE, Bioorg Med Chem Lett. 2007 Jan 1;17(1):49-52. Epub 2006 Oct 5. PMID:17055272 Page seeded by OCA on Sun May 4 07:33:27 2008